Literature DB >> 15728281

Cardiovascular risk factors and migraine: the GEM population-based study.

A I Scher1, G M Terwindt, H S J Picavet, W M M Verschuren, M D Ferrari, L J Launer.   

Abstract

BACKGROUND: Migraine, particularly with aura, is a risk factor for early-onset ischemic stroke. The underlying mechanisms are unknown, but may in part be due to migraineurs having an increased risk profile for cardiovascular disease. In this study, the authors compare the cardiovascular risk profile of adult migraineurs to that of nonmigraineurs.
METHODS: Participants (n = 5,755, 48% men, age 20 to 65 years) are from the Genetic Epidemiology of Migraine (GEM) study, a population-based study in the Netherlands. A total of 620 current migraineurs were identified: 31% with aura (MA), 64% without aura (MO), and 5% unclassified. Controls were 5,135 individuals without lifetime migraine. Measured cardiovascular risk factors included blood pressure (BP), serum total and high-density lipoprotein cholesterol (TC, HDL), smoking, oral contraceptive use, and the Framingham risk score for myocardial infarction or coronary heart disease (CHD) death.
RESULTS: Compared to controls, migraineurs were more likely to smoke (OR = 1.43 [1.1 to 1.8]), less likely to consume alcohol (OR = 0.58 [0.5 to 0.7]), and more likely to report a parental history of early myocardial infarction. Migraineurs with aura were more likely to have an unfavorable cholesterol profile (TC > or = 240 mg/dL [OR = 1.43 (0.97 to 2.1)], TC:HDL ratio > 5.0 [OR = 1.64 (1.1 to 2.4)]), have elevated BP (systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg [OR = 1.76 (1.04 to 3.0)]), and report a history of early onset CHD or stroke (OR = 3.96 [1.1 to 14.3]); female migraineurs with aura were more likely to be using oral contraceptives (OR = 2.06 [1.05 to 4.0]). The odds of having an elevated Framingham risk score for CHD were approximately doubled for the migraineurs with aura.
CONCLUSIONS: Migraineurs, particularly with aura, have a higher cardiovascular risk profile than individuals without migraine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728281     DOI: 10.1212/01.WNL.0000151857.43225.49

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  109 in total

Review 1.  Migraine and cardiovascular diseases.

Authors:  G Pierangeli; G Giannini; V Favoni; L Sambati; S Cevoli; P Cortelli
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 2.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  Migraine as a risk factor for young patients with ischemic stroke: a case-control study.

Authors:  Yasin Abanoz; Yeşim Gülen Abanoz; Ayşegül Gündüz; Derya Uludüz; Birsen İnce; Burcu Yavuz; Baki Göksan
Journal:  Neurol Sci       Date:  2017-01-12       Impact factor: 3.307

4.  Metabolic syndrome and insulin resistance in migraine.

Authors:  Sanjeev K Bhoi; Jayantee Kalita; Usha K Misra
Journal:  J Headache Pain       Date:  2012-01-26       Impact factor: 7.277

5.  A high-density association screen of 155 ion transport genes for involvement with common migraine.

Authors:  Dale R Nyholt; K Steven LaForge; Mikko Kallela; Kirsi Alakurtti; Verneri Anttila; Markus Färkkilä; Eija Hämaläinen; Jaakko Kaprio; Mari A Kaunisto; Andrew C Heath; Grant W Montgomery; Hartmut Göbel; Unda Todt; Michel D Ferrari; Lenore J Launer; Rune R Frants; Gisela M Terwindt; Boukje de Vries; W M Monique Verschuren; Jan Brand; Tobias Freilinger; Volker Pfaffenrath; Andreas Straube; Dennis G Ballinger; Yiping Zhan; Mark J Daly; David R Cox; Martin Dichgans; Arn M J M van den Maagdenberg; Christian Kubisch; Nicholas G Martin; Maija Wessman; Leena Peltonen; Aarno Palotie
Journal:  Hum Mol Genet       Date:  2008-08-02       Impact factor: 6.150

6.  Fasting lipid and lipoproteins concentrations in pregnant women with a history of migraine.

Authors:  Bizu Gelaye; Gloria T Larrabure-Torrealva; Chunfang Qiu; Miguel Angel Luque-Fernandez; B Lee Peterlin; Sixto E Sanchez; Michelle A Williams
Journal:  Headache       Date:  2015-04-22       Impact factor: 5.887

7.  Association between Chlamydia pneumoniae IgG antibodies and migraine.

Authors:  QiHong Lu; Jinzh Xu; HongYan Liu
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

Review 8.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

9.  Body mass index, migraine, migraine frequency and migraine features in women.

Authors:  A C Winter; K Berger; J E Buring; T Kurth
Journal:  Cephalalgia       Date:  2009-02       Impact factor: 6.292

Review 10.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.